“…Some of the variability in the preclinical studies likely stems from variability in methodological approaches to sample relevant data. For example, some studies rely on noncontingent (bottle or vapor) ethanol delivery (Chandler et al, 2020; Lallemand et al, 2007; Marshall et al, 2003; Potthoff et al, 1983; Smith et al, 1999), while others utilize contingent operant protocols for ethanol self-administration (Barrett et al, 2020; Deehan et al, 2015; Doyon et al, 2013; Lárraga et al, 2017). Likewise, nicotine administration in those previous studies also varied with nicotine consumed noncontingently through drinking solutions (Lallemand et al, 2007; Marshall et al, 2003; Potthoff et al, 1983), contingently through drinking solutions (Deehan et al, 2015), noncontingently using systemic injections (Barrett et al, 2020; Doyon et al, 2013; Smith et al, 1999), or contingently using intravenous self-administration protocols (Chandler et al, 2020; Lárraga et al, 2017).…”